KG&L Capital Management LLC Takes Position in Zoetis Inc. (NYSE:ZTS)

KG&L Capital Management LLC purchased a new stake in Zoetis Inc. (NYSE:ZTS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,850 shares of the company's stock, valued at approximately $790,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new stake in Zoetis in the third quarter valued at $31,000. First Personal Financial Services acquired a new stake in Zoetis in the third quarter valued at $33,000. Capital Performance Advisors LLP acquired a new stake in Zoetis in the third quarter valued at $33,000. Dunhill Financial LLC increased its position in shares of Zoetis by 80.6% during the third quarter. Dunhill Financial LLC now owns 168 shares of the company's stock worth $33,000 after purchasing an additional 75 shares in the last quarter. Finally, Quarry LP increased its position in shares of Zoetis by 273.2% during the second quarter. Quarry LP now owns 209 shares of the company's stock worth $36,000 after purchasing an additional 153 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on ZTS. UBS Group began coverage on Zoetis in a research report on Monday, December 9th. They set a "neutral" rating and a $196.00 target price on the stock. Morgan Stanley cut their target price on Zoetis from $248.00 to $243.00 and set an "overweight" rating on the stock in a research report on Wednesday, January 29th. Stifel Nicolaus cut their target price on Zoetis from $210.00 to $180.00 and set a "buy" rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. raised their price target on Zoetis from $225.00 to $230.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Finally, Leerink Partners began coverage on Zoetis in a report on Monday, December 2nd. They set an "outperform" rating and a $215.00 price target on the stock. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $215.00.

Zoetis Stock Performance

ZTS traded up $0.30 during trading on Tuesday, reaching $172.24. The company's stock had a trading volume of 2,696,175 shares, compared to its average volume of 2,685,644. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The company's fifty day moving average price is $169.48 and its 200-day moving average price is $179.39. The company has a market capitalization of $77.71 billion, a price-to-earnings ratio of 32.38, a price-to-earnings-growth ratio of 2.72 and a beta of 0.90. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts' consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. During the same quarter in the previous year, the company earned $1.36 EPS. The firm's revenue for the quarter was up 11.6% compared to the same quarter last year. On average, equities analysts forecast that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Tuesday, January 21st. This is a positive change from Zoetis's previous quarterly dividend of $0.43. Zoetis's payout ratio is currently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.